Lawsuit: Birth control mix-up results in 113
Lawsuit: Birth control mix-up results in 113 pregnancies
By MARYCLAIRE DALE
Associated Press
The lawsuit, filed in Philadelphia, is brought against Qualitest Inc., a subsidiary of the Irish drug-maker Endo Pharmaceuticals Inc., but names Patheon as well as Vintage Pharmaceuticals as defendants
PHILADELPHIA (AP) - More than 100 women who blame their pregnancies on errant birth control packaging have joined a negligence lawsuit filed in Philadelphia against several drug companies.
The lawsuit follows a 2011 recall of more than 500,000 blister packs after an Iowa customer found the pills packaged out of order, potentially increasing the chance of getting pregnant.
All but four of the 117 women involved in the lawsuit became pregnant and 94 went on to give birth.
They are now suing Endo Pharmaceuticals Inc. and other companies that made or distributed the pills under various brand names. The women are seeking damages for lost income, medical costs and, in some cases, the cost of raising their children.
A spokeswoman at Endo's U.S. headquarters in Malvern did not immediately return a message Thursday seeking comment.
The lawsuit filed last week in Philadelphia came days after a federal judge in Georgia refused to grant class-action certification to a similar suit filed there.
U.S. District Judge Steve C. Jones noted in his ruling that only 53 of the half-million recalled blister packs had the pills arranged in reverse order in the package. He said that each woman's case was unique - given whether she became pregnant, whether she carried the pregnancy to term, the relevant laws in her state, and whether she kept the package or receipt - and should be weighed individually.
"It is not enough that each class member prove that defendants sold a defective product," Jones wrote. "Each plaintiff must show in an individualized manner which 'physical symptoms' she suffered, her medical history, and whether her use of any allegedly defective product resulted in these physical symptoms or a pregnancy."
The recall involved the brand names Cyclafem, Emoquette, Gildess, Orsythia, Previfem and Tri-Previfem.
Each packet of birth control contains 28 days' worth of pills, with 21 containing hormones that prevent pregnancy and seven placebos pills. Women are supposed to take the pills in order and not mix the placebos with the active pills. The pills are normally color-coded to note the difference.
Laws in some states allow women to sue over the cost of raising a child to age 18, according to lawyer Keith Bodoh of Marietta, Georgia, who filed the Philadelphia lawsuit. Damages in a few states could include the cost of college. But the formula in four states involves the cost of raising a child minus the presumed benefits.
"It's amorphous, what to decide (is) the cost and benefit of rearing a child," Bodoh said this week
Endo International plc (ENDPQ) Stock Research Links
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Veteran suicide is a crisis staring us square in the face, with rates 60% higher than the general population. It's a grim reminder that the mental toll on those who've served is a deep chasm hard to bridge. Cohen Veterans Network (CVN) is stepping up to the plate with a new campaign dubbed 'Ask Anyway: Conversations to Save a Life'. This isn't just any awareness...
Continue Reading
Cracking the Challenger Code: BOC Group's Debut Ever heard of BOC Group? If you haven’t, it’s time to pay attention. This Dublin-based outfit just muscled its way into the Challenger Quadrant of the 2026 Gartner Magic Quadrant for Digital Twin of an Organization Platforms. Not bad for its first trip to the dance. When a company crashes the scene like this, eyebrows...
Continue Reading
RMI and Moore Team Up for Strategic Evolution Let me tell ya, RMI Direct Marketing deciding to join forces with Moore’s AudienceFirst Media is a decision that’ll ripple through the data-driven waters for quite some time. They ain’t merging, mind you, but they’re definitely tying their ships together with a shared compass set on list management and brokerage...
Continue Reading
Conference Spotlight: Endoscopic Brow Lift Plastic surgeons from across the globe are gathering in Crete, Greece, for a conference that promises to shake up the aesthetic world. Among the big names is Dr. John M. Anastasatos, who'll be lifting more than just eyebrows with his presentation on the endoscopic brow lift. This isn't just another facelift spiel—no sir—this...
Continue Reading
Diving into Hands-On Healthcare Training Opportunities Alright, let's talk straight about what's on the docket at the Institute of Medical and Business Careers (IMBC). They've just thrown open the doors for fall enrollment at their Erie and Pittsburgh campuses, focusing on getting folks trained up quick for the healthcare trenches. We're talking about roles that are...
Continue Reading
Legal Storm Brews for Soleno's Execs When you see Kuehn Law stepping into the ring, you know someone’s ruffling feathers. And this time, the target is Soleno Therapeutics (NASDAQ:SLNO), a name that might ring bells for tech folks dabbling in biotech. They’re under the spotlight because a federal securities lawsuit claims a questionable playbook was in the shuffle....
Continue Reading
Business stepping up to bat for justice reform? Yeah, that’s what's shaking over in Washington, D.C. this Constitution Day. We're seeing a gathering of senior business execs, policymakers, and public safety advocates, intent on driving judicial reform in the U.S. Usually, the suits in these rooms talk about profit margins and quarterly results, but this time they're...
Continue Reading
A Trusted Name in Healthcare Steps Up When a healthcare player like Baystate Health decides to jump into the deep end with an expansion project, you know they're not just doodling on napkins. With a legacy stretching back to 1883, Baystate Health, anchored deeply in western New England, isn't just expanding for fun—it's a move to cement its position as a crucial...
Continue Reading
stackArmor: Carving a Niche in Federal Cybersecurity Hey, not every day you wake up to find a company carving its niche in federal cybersecurity quite the way stackArmor is doing. They've recently got their hands on that elusive FedRAMP High authorization for The Armory. What's this mean in English? Well, for starters, these guys are showing they're serious about...
Continue Reading
Equinix's Nordic Expansion: A Bold Move Ever seen a chess master make a move that completely shifts the board? That's what Equinix, Inc. and CPP Investments just pulled off with their acquisition of atNorth. With a hefty price tag of $4 billion, they're not just playing around. This deal puts Equinix at the center of the Nordic data hub, solidifying its foothold in a...
Continue Reading
Top 5 Most Recently Viewed Articles
MoonLake Immunotherapeutics Under Investigation Recently, there has been significant attention surrounding MoonLake Immunotherapeutics (NASDAQ: MLTX) as the company faces an investigation over potential securities violations. Investors have raised concerns regarding whether they were misled by the company's communications regarding its clinical trials, particularly the...
Continue Reading
Transforming Artisanal Gold Mining through Innovative Solutions As gold prices soar, reaching unprecedented levels, the urgency to address the challenges posed by artisanal gold mining becomes even more crucial. Conservation X Labs (CXL) has recently shared a significant report that sheds light on vital technologies designed to mitigate the negative effects associated...
Continue Reading
Understanding the Growth of the Insight Engines Market In today's data-driven world, insight engines are becoming crucial for businesses aiming to extract valuable information from massive datasets. The insight engines market is not just a passing trend; it is projected to experience substantial growth, expanding from USD 1.7 billion in 2023 to USD 5.6 billion by 2028....
Continue Reading
Market Growth and Projections The Feminine Hygiene Products Market is on a promising trajectory, projected to expand significantly in the coming years. Recent insights indicate that the market was valued at approximately USD 27.05 billion in 2023, with expectations to reach around USD 47.98 billion by 2032. This growth translates to a compound annual growth rate (CAGR) of...
Continue Reading
Caro Holdings and Drunken Horse Gin Join Forces for Growth Caro Holdings Inc. is excited to announce a partnership with Drunken Horse Gin as they embark on a journey to enhance seasonal sales through innovative e-commerce strategies and targeted digital marketing campaigns. This collaboration aims to significantly boost Drunken Horse Gin's online presence during critical...
Continue Reading